Diuretic lowers heart failure risk
Chlorthalidone lowers the risk of new-onset hospitalised heart failure with preserved ejection fraction (HFPEF) and heart failure with reduced left ventricular ejection fraction (HFREF) compared with amlodipine and doxazosin, US researchers say.
An analysis of data from 900 participants in the ALLHAT trial showed chlorthalidone reduced the risk of HFPEF by 31% compared with amlodipine, 26% compared with lisinopril and 47% compared with doxazosin.
With HFREF, chlorthalidone was associated with a lower risk than amlodipine or doxazosin, but was similar to lisinopril.
Circulation 2008 10 November early online publication